ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1987

Predictors of Adverse Outcomes in Patients with Childhood-Onset Systemic Lupus Erythematosus Transitioning to Adult Care

Nicole Bitencourt1, Una Makris1, Elizabeth Solow1, Tracey Wright2 and Bonnie Bermas3, 1UT Southwestern Medical Center, Dallas, TX, 2UT Southwestern, Plano, TX, 3UTSouthwestern.edu, Dallas, TX

Meeting: ACR Convergence 2020

Keywords: Health Services Research, Pediatric rheumatology, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2020

Title: Pediatric Rheumatology – Clinical II: Outcomes & Care Delivery (1983–1987)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: The transition from pediatric to adult care is a vulnerable period and is linked to increased healthcare utilization and poor outcomes. We sought to identify risk factors associated with an unsuccessful transfer to adult care in childhood-onset systemic lupus erythematosus (cSLE).

Methods: A retrospective analysis of patients with cSLE seen in adult public or private rheumatology clinics was performed. Outcomes of interest were development of end-stage renal disease (ESRD) or death and time to first hospitalization following the final pediatric rheumatology visit. Independent variables included sociodemographic and disease characteristics. Pediatric factors influencing ESRD or death were assessed using Chi-square, Fisher’s test, or the Wilcoxon rank-sum test. A stepwise multivariable logistic regression model to predict ESRD or death was used. Pediatric factors influencing time to first hospitalization were assessed using the log-rank test. Stepwise multivariable Cox regression analysis was performed to define predictors of time to adult hospitalization.

Results: Of 190 patients with cSLE, 21 (11%) developed ESRD and 9 (5%) died following the final pediatric rheumatology visit. As seen in Figure 1, ESRD or death were more common among patients of Black race or Hispanic ethnicity, those with public insurance, a history of child protective services (CPS) involvement or abuse, an outpatient narcotic prescription for non-procedural pain management during pediatric care, a history of unscheduled hospitalization, emergency department (ED) visit, or at least one no-show visit during the final year in pediatric care, and prior cyclophosphamide therapy (p< 0.03). Gender, age at transfer, SLE disease duration, and income based on zip-code were not significantly related to development of ESRD or death. In logistic regression, public insurance, history of CPS involvement or abuse, and an unscheduled pediatric hospitalization were associated with development of ESRD or death (Table 1).

Of 114 patients for whom healthcare utilization data were available following final pediatric visit, 53% had a hospitalization in adult care. Time interval to first adult hospitalization was shorter for patients of Black race or Hispanic ethnicity, those with public insurance, a history of CPS involvement or abuse, an outpatient narcotic prescription for non-procedural pain management during pediatric care, a history of unscheduled hospitalization, ED visit, and no-show visit during the final year in pediatric care (p< 0.03) (Figure 2). In Cox regression analysis, a pediatric outpatient narcotic prescription was associated with shorter time to hospitalization while White or Asian race was associated with longer time to first hospitalization (p< 0.007).

Conclusion: Our findings indicate that efforts to improve transition outcomes among patients with cSLE should focus on high risk individuals in pediatric care, including those of Black race or Hispanic ethnicity, patients with public insurance, a history of CPS involvement or abuse, outpatient narcotic prescription for non-procedural pain management, and history of hospitalization, ED visit or no-show visit in the final year of pediatric care.

Figure 1. Pediatric Factors Associated with ESRD or Death after Transfer to Adult Care

Figure 2. Time to Adult Hospitalization by Pediatric Factors

Table 1. Stepwise Regression Models of Pediatric Predictors of Outcomes in SLE


Disclosure: N. Bitencourt, None; U. Makris, None; E. Solow, None; T. Wright, None; B. Bermas, None.

To cite this abstract in AMA style:

Bitencourt N, Makris U, Solow E, Wright T, Bermas B. Predictors of Adverse Outcomes in Patients with Childhood-Onset Systemic Lupus Erythematosus Transitioning to Adult Care [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/predictors-of-adverse-outcomes-in-patients-with-childhood-onset-systemic-lupus-erythematosus-transitioning-to-adult-care/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-adverse-outcomes-in-patients-with-childhood-onset-systemic-lupus-erythematosus-transitioning-to-adult-care/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology